Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use

Completed · Not applicable

Conditions studied: Pulmonary Embolism, Venous Thromboembolism, Atrial Fibrillation

In brief

The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to prescribers. Furthermore, the researchers hypothesize that the availability of a pharmacist referral option is associated with a higher rate of prescription changes for initial-prescription alerts that are directed to the prescriber at the time of initial-prescribing errors. Findings from this project will establish a framework for implementing prescriber-pharmacist collaboration for high risk medications, including anticoagulants

Key facts

Study ID

NCT05351749

Run by

University of Michigan

People needed

306

Starts

2022-08-01

Expected to finish

2024-12-15

Last updated by the study team

2026-03-30

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Michigan Medicine provider with prescribing privileges
• Providers in ambulatory care settings
• Prescribe DOAC to patients 18 years and older

You may not qualify if…

• Providers in inpatient settings
• Providers who are members of the study team

Where it is running

• University of Michigan — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.